查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018754

血栓除去裝置市場：按器械類型、最終用戶和應用分類 - 2026-2032年全球市場預測

Blood Clot Retrieval Devices Market by Device Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血栓除去裝置市場價值將達到 23 億美元，到 2026 年將成長至 26.4 億美元，到 2032 年將達到 60.6 億美元，複合年成長率為 14.80%。

主要市場統計數據
基準年 2025 23億美元
預計年份：2026年 26.4億美元
預測年份 2032 60.6億美元
複合年成長率 (%) 14.80%

簡要概述正在重塑血栓除去裝置和治療過程的技術、臨床和監管因素。

血栓除去裝置以及最大限度減少取出過程中的遠端栓塞。影像導引和導管技術的同步發展，創造了一個協同效應良好的環境，使得裝置設計、手術流程和臨床方案能夠同步演進。

融合的技術進步、臨床方案的改革以及不斷發展的經營模式如何從根本上改變血栓除去裝置的格局？

血栓除去裝置市場正經歷著一場變革，其驅動力包括技術進步、臨床方案的不斷改進以及人們對治療效果和成本的預期不斷變化。在器械層面，製造商正在推出混合結構，將機械支架樣元件與抽吸功能結合。這些混合設計旨在提高首次手術成功率，同時降低手術複雜性。同時，影像和導航平台使得器械能夠更精準地放置在遠端和彎曲的解剖結構中，從而擴大了可治療病變的範圍，並促使人們重新評估介入治療標準。

本研究分析了 2025 年美國關稅對設備採購、定價策略和供應鏈韌性的多方面營運和商業影響。

2025年關稅和貿易措施的實施，為依賴全球零件和成品的製造商、經銷商和醫療保健系統帶來了新的挑戰。關稅帶來的成本壓力體現在價值鏈的多個環節，包括原料採購、契約製造和跨境分銷。這些成本的增加迫使製造商重新評估供應商選擇標準，探索替代材料和零件，並盡可能加快關鍵製造流程的本地化。因此，近岸外包和產能多元化策略正從緊急措施轉變為主動的供應鏈重組。

將設備架構、臨床環境和特定適應症的程序要求聯繫起來的實用分割訊息，以促進開發和採購。

細分市場分析揭示了產品開發、臨床應用和籌資策略如何因醫療設備類型、臨床環境和臨床適應症的不同而有所差異。就醫療設備類型而言，抽吸導管的操作流程以直接抽吸為中心，常用於預期有柔軟易碎血栓的情況。而血栓摘取支架則提供機械捕獲和徑向支撐，適用於已形成血栓的情況。此外，整合了抽吸和取栓機制的組合系統旨在捕捉更多種類的血栓形態，同時最佳化初始介入的有效性，無論採用順序實施或同時實施。這些差異會影響研發優先順序、臨床訓練需求以及治療機構的庫存策略。

區域醫療保健基礎設施、監管多樣性和能力建設優先事項如何影響不同的部署模式和打入市場策略。

區域趨勢塑造了臨床實踐模式、監管路徑和供應鏈設計，進而對醫療器材的採用和供應商策略產生重大影響。在美洲，緊密的三級醫療中心網路和綜合中風系統正在加速手術流程的標準化，許多醫療機構也在投資建設中風緊急基礎設施和多學科中風團隊。這種環境不僅推動了那些展現出明顯手術優勢和可衡量的工作流程效率提升的醫療器材的快速普及，也使那些提供全面培訓和上市後結果分析的供應商受益。

以臨床差異化、服務整合和生命週期組合管理為重點，制定具有競爭力和協作性的企業策略，以確保永續應用。

血栓除去裝置領域的競爭格局呈現出多元化的態勢，既有成熟的平台型企業，也有創新新興企業，還有利用自身手術資源和服務生態系統來提升產品普及率的垂直整合型醫療設備公司。無論主要企業還是新晉參與企業，都致力於透過顯著的手術優勢來實現臨床差異化，例如提高首次手術成功率、減少器械更換次數以及簡化操作流程。為了實現這些目標，各公司都在投資於器械的迭代最佳化、支持輔助手術的模組化系統以及旨在縮短學習曲線並建立最佳實踐的全面臨床醫生培訓計畫。

為製造商和醫療保健系統提供具體可行的建議，以協調臨床證據、培訓、供應彈性和基於價值的商業模式。

在醫療程序期望不斷提高、供應鏈日益複雜的環境下，行業領導企業可以採取實際措施，協調其商業性、臨床和營運目標。首先，從產品開發的早期階段就整合臨床證據的獲取，可以確保醫療器材符合實際的手術需求和監管要求，同時也能產生採購委員會所需的比較結果。透過將臨床試驗設計與目標終端使用者相匹配，企業可以產生與心臟病醫院、神經血管中心和高運作門診機構直接相關的證據。

一種高度透明的三角測量型調查方法，結合了初步臨床觀察、程序資料檢驗和監管途徑分析，以得出實際結論。

本報告的研究採用了一種三角測量法，整合了對關鍵相關人員的訪談、對手術數據的分析以及對監管和臨床文獻的回顧。關鍵資料來源包括對介入臨床醫生、醫院採購經理和器械工程師的結構化訪談，以了解他們對器械性能、工作流程影響以及採購決策者的第一手觀點。這些定性見解與手術結果資料集和同行評審的臨床研究進行了交叉比對，以檢驗性能聲明並識別器械選擇和臨床決策中的模式。

策略結論強調了臨床表現、證據產生和供應韌性如何共同決定血栓切除技術的持續應用。

總之，血栓切除術領域融合了先進的器械工程、涉及重大風險的臨床決策以及複雜的商業性動態。器械結構和影像引導技術的創新正在拓展可治療的手術範圍，而臨床工作流程和認證標準的變革則提高了器械性能和手術效率的要求。關稅和區域監管差異造成的供應鏈壓力進一步凸顯了穩健的生產體系和差異化打入市場策略的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：血栓除去裝置市場：依器械類型分類

  • 吸痰管
  • 複合系統
    • 順序檢索器
    • 同時檢索型檢索器
  • 血栓摘取支架

第9章：血栓除去裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 心臟病醫院
    • 神經血管中心
  • 血管專科診所

第10章：血栓除去裝置市場：依應用領域分類

  • 深層靜脈栓塞症
    • 遠端深層靜脈栓塞症
    • 近端深層靜脈栓塞症
  • 缺血性中風
    • 急性缺血性腦中風
    • 亞急性及慢性閉塞
  • 肺動脈栓塞
    • 大面積肺動脈栓塞
    • 亞大塊肺動脈栓塞

第11章：血栓除去裝置市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：血栓除去裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：血栓除去裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國血栓除去裝置市場

第15章：中國血栓除去裝置市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3D Matrix Medical Technologies
  • Abbott Laboratories
  • Acandis GmbH
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • Balt USA, LLC
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Insera Therapeutics, Inc.
  • InspireMD, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-A26E0E574192

The Blood Clot Retrieval Devices Market was valued at USD 2.30 billion in 2025 and is projected to grow to USD 2.64 billion in 2026, with a CAGR of 14.80%, reaching USD 6.06 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.30 billion
Estimated Year [2026] USD 2.64 billion
Forecast Year [2032] USD 6.06 billion
CAGR (%) 14.80%

A concise introduction to the technological, clinical, and regulatory forces reshaping blood clot retrieval devices and procedural pathways

Blood clot retrieval devices have advanced from rudimentary mechanical implements to highly engineered endovascular systems capable of rapidly restoring perfusion in life-threatening thrombotic events. Over the past decade, device innovation has concentrated on improving navigability within tortuous vasculature, enhancing clot engagement and extraction efficiency, and minimizing distal embolization during retrieval. Concurrent advancements in imaging guidance and catheter technology have created a synergistic environment in which device design, procedural techniques, and clinical protocols evolve in concert.

In clinical settings, the emphasis has shifted toward time-sensitive interventions where device performance directly affects neurological and cardiopulmonary outcomes. As a result, multidisciplinary teams that integrate interventional neurologists, vascular surgeons, and interventional radiologists are increasingly standardizing procedural pathways to optimize door-to-reperfusion times. Meanwhile, manufacturers are pursuing iterative improvements and novel architectures that prioritize trackability, radial force control, and aspiration compatibility to accommodate a wider range of clot compositions and anatomical variations.

Regulatory engagement and evidence generation have also matured. Device approvals now commonly require robust procedural data, comparative metrics against established techniques, and post-market surveillance commitments. Consequently, strategic planning for device development must encompass clinical trial design, health economic modeling, and early stakeholder engagement to support hospital adoption and payer dialogue. Taken together, these forces frame an environment where clinical efficacy, procedural efficiency, and supply chain resilience all shape the competitive contours of the sector.

How convergent technological advances, clinical pathway reforms, and evolving commercial models are fundamentally transforming the blood clot retrieval device landscape

The landscape for clot retrieval devices is undergoing transformative shifts driven by converging technological advances, evolving clinical protocols, and changing ecosystem expectations around outcomes and cost. At the device level, manufacturers are introducing hybrid architectures that combine mechanical stent-like elements with aspiration-compatible lumens, and those hybrid designs aim to improve first-pass efficacy while reducing procedural complexity. Simultaneously, imaging and navigation platforms have enabled more precise device deployment in distal and tortuous anatomy, expanding the range of treatable lesions and prompting re-evaluation of inclusion criteria for intervention.

Clinically, care pathways are becoming more integrated as stroke systems of care and vascular programs prioritize rapid triage, pre-hospital notification, and streamlined in-hospital workflows. This operational emphasis has incentivized devices that reduce procedure time and variability, and it has elevated metrics such as first-pass success and minimized device exchanges. In parallel, cross-disciplinary training and simulation-based credentialing are reducing operator-dependent variability, which in turn influences purchasing decisions and vendor support models.

From a strategic standpoint, these shifts are prompting suppliers to rethink commercial models. Providers increasingly value bundled offerings that include training, real-time procedural support, and data analytics to monitor outcomes. At the same time, global supply chain considerations and the desire for diversified manufacturing footprints are encouraging partnerships and regionalized production strategies. Together, these changes are not incremental; they are redefining expectations across clinical performance, service models, and competitive differentiation.

Analyzing the multifaceted operational and commercial repercussions of United States tariffs in 2025 on device sourcing, pricing strategies, and supply chain resilience

The imposition of tariffs and trade measures in 2025 has introduced new layers of complexity for manufacturers, distributors, and health systems that rely on globally sourced components and finished devices. Tariff-induced cost pressures manifest across multiple nodes of the value chain, including raw-material procurement, contract manufacturing, and cross-border distribution. These increased costs compel manufacturers to re-evaluate supplier selection criteria, explore alternative materials or components, and accelerate initiatives to localize critical manufacturing steps where feasible. As a consequence, nearshoring and capacity diversification strategies have moved from contingency planning to active supply chain redesign.

In addition to direct cost implications, tariffs influence pricing negotiations with healthcare providers and payers, particularly in regions where reimbursement rates are constrained. Hospitals and ambulatory surgical centers may face tighter procurement budgets and therefore prioritize devices that demonstrate robust procedural efficiency and lower ancillary service requirements. To mitigate margin compression, suppliers are pursuing value-added services, extended warranties, and outcome-based contracting to preserve commercial viability.

Regulatory and customs compliance burdens have also increased, requiring enhanced documentation, longer lead times, and greater inventory buffers to avoid procedural disruptions. These operational adaptations have ripple effects on clinical scheduling and capital procurement timelines. Therefore, forward-looking organizations are combining scenario planning with more granular visibility into supplier nodes to maintain continuity of care, manage cost volatility, and sustain product availability in the face of persistent trade friction.

Actionable segmentation intelligence linking device architectures, clinical settings, and indication-specific procedural demands to inform development and procurement

Insight into segmentation reveals how product development, clinical adoption, and procurement strategies diverge across device typologies, care settings, and clinical indications. When device type is considered, aspiration catheters offer a procedural profile centered on direct suction and are frequently selected for cases where soft, friable thrombus is anticipated; stent retrievers provide mechanical engagement and radial support suitable for organized clots; and combined systems that integrate aspiration with retriever mechanics-whether deployed sequentially or simultaneously-aim to capture a broader spectrum of thrombus morphologies while optimizing first-pass efficacy. This differentiation impacts R&D prioritization, clinical training requirements, and inventory strategies at procedural centers.

Regarding end users, ambulatory surgical centers, general hospitals, and specialized vascular clinics present distinct purchasing rationales and operational constraints. Ambulatory centers emphasize throughput and cost per episode, whereas hospitals often balance acute care readiness with capital planning across cardiac and neurovascular programs. Within hospitals, cardiac hospitals and dedicated neurovascular centers develop unique competency matrices and device formularies aligned with their dominant procedural volumes and specialist expertise. These institutional distinctions shape vendor engagement approaches, including support packages, training modalities, and preferred contract structures.

Clinical application further stratifies device selection and procedural planning. Deep vein thrombosis cases, whether distal or proximal, demand devices and techniques that preserve venous integrity and minimize post-thrombotic sequelae. Ischemic stroke interventions, spanning acute ischemic presentations and subacute or chronic occlusions, require devices optimized for cerebral vessel fragility and rapid reperfusion. Pulmonary embolism treatment, across massive and submassive presentations, necessitates systems capable of extracting large clot burdens while maintaining hemodynamic stability. Each indication imposes discrete clinical performance requirements, and therefore segmentation-aware development and commercialization strategies are essential for aligning product portfolios with procedural realities.

How regional healthcare infrastructure, regulatory diversity, and capacity-building priorities drive differentiated adoption patterns and market entry strategies

Regional dynamics shape clinical practice patterns, regulatory pathways, and supply chain design in ways that materially affect device adoption and vendor strategy. In the Americas, a dense network of tertiary centers and integrated stroke systems has accelerated procedural standardization, with many institutions investing in stroke-ready infrastructure and multidisciplinary stroke teams. This environment supports rapid adoption of devices that demonstrate clear procedural advantages and measurable improvements in workflow efficiency, and it also favors vendors that offer comprehensive training and post-market outcome analytics.

In Europe, the Middle East & Africa region, heterogeneous regulatory landscapes and variable hospital capabilities create a market where tailored entry strategies and localized clinical evidence are paramount. Providers in core European markets often emphasize comparative clinical data and health technology assessments, whereas centers in emerging markets may prioritize cost-effectiveness and supply reliability. Consequently, manufacturers often pursue differentiated market access approaches, combining robust clinical dossiers in regulated markets with targeted capacity-building initiatives and flexible commercial models in varied healthcare settings.

In the Asia-Pacific region, rapid urbanization, expanding tertiary care networks, and investments in interventional training are driving procedural volumes upward. This growth is accompanied by an emphasis on scalable solutions that cater to high-volume centers while remaining accessible to regional hospitals. Regulatory harmonization efforts and increasing local manufacturing investments are also shaping the competitive environment, prompting multinational suppliers to consider regional partnerships and production footprints to support faster market entry and sustainable operations.

Competitive and collaborative company strategies focused on clinical differentiation, service integration, and lifecycle portfolio management to secure durable adoption

Competitive dynamics in the clot retrieval device space reflect a blend of entrenched platform players, innovative challengers, and vertically integrated medical device companies that leverage surgical capital and service ecosystems to strengthen adoption. Leading manufacturers and emerging entrants alike focus on clinical differentiation through demonstrable procedural benefits such as increased first-pass success, reduced device exchanges, and simplified operator workflows. To achieve these outcomes, companies are investing in iterative device optimization, modular systems that support complementary procedural techniques, and comprehensive clinician education programs that shorten learning curves and reinforce best practices.

Moreover, strategic partnerships and licensing arrangements are increasingly prevalent as firms seek to accelerate time-to-market and broaden product portfolios without incurring the full cost of in-house development. These collaborative models extend to distribution agreements, clinical research consortia, and shared manufacturing capacity. Vendors that pair device innovation with strong service offerings-such as intra-procedural support, simulation training, and data analytics-tend to establish stickier relationships with high-volume centers and specialty programs.

Finally, corporate strategies are integrating lifecycle management plans that consider incremental device improvements, compatibility across product families, and post-market surveillance commitments. This long-view approach to portfolio management helps firms navigate regulatory expectations while maintaining clinical relevance and supporting hospital procurement committees that prioritize demonstrable long-term value.

Concrete, implementable recommendations for manufacturers and health systems to align clinical evidence, training, supply resilience, and value-based commercial models

Industry leaders can take concrete steps to align commercial, clinical, and operational objectives in an environment of accelerating procedural expectations and supply chain complexity. First, integrating clinical evidence generation into product development from early stages will ensure that devices meet practical procedural needs and regulatory requirements, while also producing the comparative outcomes required by procurement committees. By coordinating clinical trial design with target end users, companies can generate evidence that is directly relevant to cardiac hospitals, neurovascular centers, and high-volume ambulatory facilities alike.

Second, investing in comprehensive training and procedural support programs reduces operator variability and strengthens vendor ties with institutions. Simulation-based credentialing, on-demand procedural coaching, and structured post-procedure debriefs help embed new devices into clinical workflows and enhance first-pass performance metrics. Third, supply chain resilience must be prioritized through diversified sourcing, strategic inventory positioning, and potential regional manufacturing partnerships to mitigate tariff-related cost pressures and logistics disruptions. Aligning procurement timelines with hospital capital cycles and enhancing visibility across supplier nodes will further reduce operational friction.

Finally, commercial models should evolve to include outcome-oriented contracting, bundled services, and flexible pricing structures that reflect the value of procedural efficiency and reduced complication rates. These approaches make it easier for hospitals to justify adoption while preserving vendor margins in price-sensitive environments. By combining evidence generation, training, supply chain robustness, and adaptive commercial strategies, leaders can position their portfolios for sustainable adoption and competitive resilience.

A transparent, triangulated research methodology combining primary clinician insights, procedural data validation, and regulatory pathway analysis to ensure actionable conclusions

The research underpinning this report applied a triangulated methodology that integrates primary stakeholder interviews, procedural data analysis, and regulatory and clinical literature review. Primary inputs included structured interviews with interventional clinicians, hospital procurement leaders, and device engineers to capture frontline perspectives on device performance, workflow impacts, and purchasing determinants. These qualitative insights were cross-referenced with procedural outcome datasets and peer-reviewed clinical studies to validate performance claims and to identify patterns in device selection and clinical decision-making.

In parallel, regulatory filings and guidance documents were analyzed to map approval pathways, post-market surveillance expectations, and labeling constraints across major jurisdictions. Supply chain assessments incorporated supplier network mapping, component sourcing analysis, and conversations with contract manufacturers to understand production bottlenecks and opportunities for supply diversification. The synthesis of these streams facilitated a comprehensive view of device lifecycle considerations, from design and clinical adoption to commercialization and post-market support.

Throughout, care was taken to ensure that interpretations remain grounded in current clinical practice and regulatory realities. Transitional checks and iterative peer reviews with subject-matter experts were employed to maintain fidelity to evolving procedural standards and to ensure the research outputs remain actionable for decision-makers in manufacturing, clinical operations, and procurement.

A strategic conclusion highlighting how clinical performance, evidence generation, and supply resilience converge to determine durable adoption of clot retrieval technologies

In conclusion, the blood clot retrieval space sits at the intersection of sophisticated device engineering, high-stakes clinical decision-making, and complex commercial dynamics. Innovation in device architecture and imaging guidance is expanding the boundaries of what is treatable, while changes in clinical workflows and credentialing are raising the bar for device performance and procedural efficiency. Tariff-driven supply chain stresses and regional regulatory heterogeneity further underscore the necessity for resilient manufacturing footprints and differentiated market-access strategies.

To navigate this environment, stakeholders must align product development with the real-world needs of diverse end users, generate robust clinical evidence that speaks to procedural outcomes, and implement flexible commercial models that recognize the operational realities of hospitals and specialty clinics. By doing so, manufacturers and health systems can not only manage near-term disruptions but also capitalize on longer-term shifts toward more integrated, outcome-focused care models. Ultimately, the ability to deliver clinically meaningful benefits, supported by reproducible evidence and reliable supply, will determine which solutions achieve broad and sustained adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Clot Retrieval Devices Market, by Device Type

  • 8.1. Aspiration Catheter
  • 8.2. Combined System
    • 8.2.1. Sequential Retrievers
    • 8.2.2. Simultaneous Retrievers
  • 8.3. Stent Retriever

9. Blood Clot Retrieval Devices Market, by End User

  • 9.1. Ambulatory Surgical Center
  • 9.2. Hospital
    • 9.2.1. Cardiac Hospital
    • 9.2.2. Neurovascular Center
  • 9.3. Specialized Vascular Clinic

10. Blood Clot Retrieval Devices Market, by Application

  • 10.1. Deep Vein Thrombosis
    • 10.1.1. Distal Deep Vein Thrombosis
    • 10.1.2. Proximal Deep Vein Thrombosis
  • 10.2. Ischemic Stroke
    • 10.2.1. Acute Ischemic Stroke
    • 10.2.2. Subacute And Chronic Occlusion
  • 10.3. Pulmonary Embolism
    • 10.3.1. Massive Pulmonary Embolism
    • 10.3.2. Submassive Pulmonary Embolism

11. Blood Clot Retrieval Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Blood Clot Retrieval Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Blood Clot Retrieval Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Blood Clot Retrieval Devices Market

15. China Blood Clot Retrieval Devices Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. 3D Matrix Medical Technologies
  • 16.6. Abbott Laboratories
  • 16.7. Acandis GmbH
  • 16.8. AngioDynamics, Inc.
  • 16.9. Asahi Intecc Co., Ltd.
  • 16.10. Balt USA, LLC
  • 16.11. Boston Scientific Corporation
  • 16.12. Cardinal Health, Inc.
  • 16.13. Insera Therapeutics, Inc.
  • 16.14. InspireMD, Inc.
  • 16.15. Integra LifeSciences Holdings Corporation
  • 16.16. Johnson & Johnson
  • 16.17. Medtronic plc
  • 16.18. MicroPort Scientific Corporation
  • 16.19. Penumbra, Inc.
  • 16.20. Phenox GmbH
  • 16.21. Stryker Corporation
  • 16.22. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ASPIRATION CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SEQUENTIAL RETRIEVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SIMULTANEOUS RETRIEVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY STENT RETRIEVER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY CARDIAC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY NEUROVASCULAR CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SPECIALIZED VASCULAR CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DISTAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PROXIMAL DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ACUTE ISCHEMIC STROKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBACUTE AND CHRONIC OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY MASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBMASSIVE PULMONARY EMBOLISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 155. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 180. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 182. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 186. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 189. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 191. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY COMBINED SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA BLOOD CLOT RETRIEVAL DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, 2018-2032 (USD MILLION)